BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Novuspharma SpA 

Viale G.B. Stucchi 110

Monza      Italy
Phone: 39-039-2814-1 Fax: +39-039-2814-601


SEARCH JOBS




Industry
Biotechnology






 Company News
Novuspharma SpA (IT:NOV) Release: Pixantrone Research Study Reveals No Increase In Anthracycline-Induced Heart Damage 10/19/2005 5:10:49 PM    More...
Novuspharma SpA (IT:NOV) Release: Study Reveals No Increase In Anthracycline-Induced Heart Damage With Pixantrone 10/19/2005 5:10:49 PM    More...
Novuspharma SpA (IT:NOV) Release: Impressive Data For Pixantrone In The CHOP-Variant Regimen To Be Presented At The 2003 American Society Of Haematology (ASH) Meeting 10/19/2005 5:10:28 PM    More...
Cell Therapeutics (CTIC) And Novuspharma SpA (IT:NOV) Complete Merger 10/19/2005 5:09:35 PM    More...
Commissione Nazionale Per Le Societa E La Borsa (Consob) Approves Prospectus For Listing Cell Therapeutics (CTIC) On The Nuovo Mercato 10/19/2005 5:09:34 PM    More...
Novuspharma SpA (IT:NOV) Release: Pixantrone Induces Impressive 77% Major Tumor Response Rate In Patients With Relapsed Aggressive Lymphoma When Substituted For Doxorubicin In CHOP Regimen 10/19/2005 5:09:28 PM    More...
KPMG S.p.A. Says It Was Not Independent With Respect To Novuspharma SpA (IT:NOV) 10/19/2005 5:08:59 PM    More...